Frontiers in Endocrinology
Cardiovascular outcomes of SGLT2 inhibitors versus GLP-1 receptor agonists in patients with type 2 diabetes and a history of myocardial infarction: a systematic review and network meta-analysis of randomized controlled trials
Meta-analysis of randomised trialsInterventions
Preregistered CRD420261299756
- SGLT2 inhibitors
- GLP-1 receptor agonists
- GLP-1 and incretin signalling
- Type 2 diabetes
- Myocardial infarction
- Humans
The paper
Chinese People's Liberation Army
Frontiers in Endocrinology, 29 Jul 2026
